These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16462096)

  • 21. [Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol].
    Waku K
    Yakugaku Zasshi; 2006 Feb; 126(2):67-81. PubMed ID: 16462096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid receptors and their endogenous ligands.
    Sugiura T; Waku K
    J Biochem; 2002 Jul; 132(1):7-12. PubMed ID: 12097154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
    Sugiura T; Kishimoto S; Oka S; Gokoh M
    Prog Lipid Res; 2006 Sep; 45(5):405-46. PubMed ID: 16678907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.
    Sugiura T
    Biofactors; 2009; 35(1):88-97. PubMed ID: 19319851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
    Sugiura T; Kobayashi Y; Oka S; Waku K
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [2-Arachidonoylglycerol: an endogenous cannabinoid receptor ligand].
    Sugiura T
    Seikagaku; 2007 Jul; 79(7):655-68. PubMed ID: 17763698
    [No Abstract]   [Full Text] [Related]  

  • 27. The endocannabinoid system in neurodegeneration.
    Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Arachidonoylglycerol and the cannabinoid receptors.
    Sugiura T; Waku K
    Chem Phys Lipids; 2000 Nov; 108(1-2):89-106. PubMed ID: 11106784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why do cannabinoid receptors have more than one endogenous ligand?
    Di Marzo V; De Petrocellis L
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3216-28. PubMed ID: 23108541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.
    Reggio PH
    Curr Med Chem; 2010; 17(14):1468-86. PubMed ID: 20166921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.
    Di Marzo V; Bisogno T; De Petrocellis L; Melck D; Martin BR
    Curr Med Chem; 1999 Aug; 6(8):721-44. PubMed ID: 10469888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments.
    Di Marzo V; De Petrocellis L; Bisogno T; Melck D
    Lipids; 1999; 34 Suppl():S319-25. PubMed ID: 10419192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocannabinoids: synthesis and degradation.
    Di Marzo V
    Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An introduction to the endocannabinoid system: from the early to the latest concepts.
    De Petrocellis L; Di Marzo V
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.
    Di Marzo V
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):153-75. PubMed ID: 9630590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
    Ueda N; Goparaju SK; Katayama K; Kurahashi Y; Suzuki H; Yamamoto S
    J Med Invest; 1998 Aug; 45(1-4):27-36. PubMed ID: 9864962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, and related lipid molecules in the nervous tissues.
    Sugiura T; Kondo S; Sukagawa A; Tonegawa T; Nakane S; Yamashita A; Waku K
    J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):51-6. PubMed ID: 8906545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges.
    Schmid HH; Schmid PC; Berdyshev EV
    Chem Phys Lipids; 2002 Dec; 121(1-2):111-34. PubMed ID: 12505695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand.
    Khanolkar AD; Makriyannis A
    Life Sci; 1999; 65(6-7):607-16. PubMed ID: 10462061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid receptors and their endogenous agonist, anandamide.
    Axelrod J; Felder CC
    Neurochem Res; 1998 May; 23(5):575-81. PubMed ID: 9566594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.